Electrical Stimulation & Visual Feedback for Stroke
Trial Summary
What is the purpose of this trial?
Falls are an "emerging public health crisis" that cost the Canadian health care system billions of dollars each year. Moreover falls have a significant, detrimental impact on the lives of those who fall. In addition to physical injury and hospital admission, individuals may experience a post-fall syndrome characterized by dependence, depression, and reduced mobility and participation. Individuals living with the effects of neurological disease or injury are at a particularly high risk of falling. For example, 69-78% of individuals with spinal cord injury or disease (SCI/D) and 73% of individuals post-stroke fall at least once per year. Despite this high fall risk, evidence-based initiatives to prevent falls among those with SCI/D or stroke are lacking in neurorehabilitation. Furthermore, little time is dedicated to improving balance during inpatient neurorehabilitation. For example, ambulatory inpatients with SCI/D spend, on average, a mere 2.0±2.0 hours on balance training over the course of their entire inpatient stay. Our team is developing effective solutions to the "high-volume, high-risk and high-cost challenge" of falls. Our long-term objective is to develop an intervention that improves balance in a clinically meaningful and feasible way, facilitating the recovery of safe upright mobility and addressing the current health crisis of falls in individuals living with neurological disease or injury. The intervention will be developed with a focus on neurological populations, as these patient groups have a critical need for balance training; however, the intervention will be transferrable to other populations at risk of falls, such as older able-bodied adults. A probable solution to the gap in balance interventions is functional electrical stimulation (FES), whereby an electrical current is applied to peripheral nerves to facilitate muscle contractions. By applying the appropriate amount of electrical stimulation at the appropriate time during movement execution, the central nervous system can be re-educated, facilitating motor and functional improvements. The investigators developed a closed-loop FES system whose controller mimics the physiological control system. By combining this system with visual feedback balance training (VFBT), the investigators developed a prototype system of FES and VFBT (FES+VFBT). This intervention involves standing on a force plate with one's centre of pressure (COP) presented on a monitor. As the user moves his/her COP in response to a game, FES is delivered to the plantarflexor and dorsiflexor muscles through the device, MyndSearch.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have had an injection of botulinum toxin to leg muscles in the past two weeks or plan to have one during the treatment period, you may not be eligible to participate.
What data supports the effectiveness of the treatment FES+VFBT for stroke patients?
Is functional electrical stimulation (FES) generally safe for humans?
How is the FES+VFBT treatment for stroke different from other treatments?
The FES+VFBT treatment is unique because it combines functional electrical stimulation (FES) with visual feedback to improve balance and muscle function in stroke patients. This approach uses real-time feedback from sensors to adjust muscle stimulation, which is not commonly found in other stroke rehabilitation therapies.127810
Research Team
Kristin E Musselman, PhD
Principal Investigator
KITE-Toronto Rehabilitation Institute, UHN
Eligibility Criteria
This trial is for adults over 18 who can stand on their own for a minute, understand English, and have moderate trunk control. It's specifically for those with non-progressive spinal cord injury/disease or stroke that happened over a year ago and are not improving naturally anymore. People with other conditions affecting walking/balance or specific contraindications like recent fractures, botulinum toxin injections, nerve damage in legs, certain medical devices implanted, cancer treatments within six months, uncontrolled epilepsy or skin issues at electrode sites cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive FES+VFBT intervention, involving standing on a force plate with COP presented on a monitor and FES delivered to muscles
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- FES+VFBT
FES+VFBT is already approved in Canada for the following indications:
- Balance training for individuals with neurological disease or injury
- Prevention of falls in individuals with spinal cord injury or disease (SCI/D) and stroke
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor